Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Outset Medical (OM) Other Operating Expenses (2019 - 2025)

Outset Medical (OM) has disclosed Other Operating Expenses for 7 consecutive years, with $29.9 million as the latest value for Q4 2025.

  • On a quarterly basis, Other Operating Expenses fell 4.01% to $29.9 million in Q4 2025 year-over-year; TTM through Dec 2025 was $94.3 million, a 13.97% decrease, with the full-year FY2025 number at $54.4 million, down 20.69% from a year prior.
  • Other Operating Expenses was $29.9 million for Q4 2025 at Outset Medical, up from $22.0 million in the prior quarter.
  • In the past five years, Other Operating Expenses ranged from a high of $32.3 million in Q3 2024 to a low of $13.1 million in Q1 2021.
  • A 5-year average of $22.7 million and a median of $23.1 million in 2021 define the central range for Other Operating Expenses.
  • Peak YoY movement for Other Operating Expenses: surged 80.57% in 2021, then plummeted 31.72% in 2025.
  • Outset Medical's Other Operating Expenses stood at $23.0 million in 2021, then grew by 2.78% to $23.6 million in 2022, then dropped by 6.08% to $22.2 million in 2023, then surged by 40.16% to $31.1 million in 2024, then dropped by 4.01% to $29.9 million in 2025.
  • Per Business Quant, the three most recent readings for OM's Other Operating Expenses are $29.9 million (Q4 2025), $22.0 million (Q3 2025), and $28.7 million (Q2 2025).